The stats I found put it between J&J and Phizer/Moderna
In any case, all 3, particularly P&M, in the US are highly effective. Given that, I'm also not sure why the FDA (whose job it is, not the CDC) would go through the process, including getting the Indian manufacturer onboard to bother, to add a fourth vaccine into the mix in the United States. That goes the same for the infrastructure to manufacture and distribute in the US.
Same reason the Astra-Zeneca vaccine is not in the US. Do you think Astra-Zeneca (NYSE:AZ $60.27) is being left out as part of a conspiracy over rational/logical reasons?
As for approval to 2, the ones available in the US will likely be approved soon too down to those ages. Covaxin would not be approved as quickly by the FDA vs India's CDSCO; they do not, for good reason, operate the same way.
|
(
In response to this post by BobG)
Posted: 10/13/2021 at 09:22AM